Somatic problems of HIV-Medicine: AIDS-related lymphomas

We followed 66 lymphoma -AIDS patients (pts): aggressive lymphomas were diagnosed in 48 pts (male — 35, female — 13, median age 32.5±1.2) and Hodgkin's lymphoma was established in 18 pts (male — 14, female — 4, median age 34.1±2.3). Median duration time from HIV exposure to the onset of lymphom...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Pivnik, Y. G. Parhomenko, Y. A. Krivolapov, O. A. Tishkevich, V. G. Korovushkin, A. M. Kovrigina, M. B. Grusdev, L. D. Grinshpun, I. A. Berdisheva, N. V. Seregin, A. O. Tuaeva, E. B. Likunov, D. V. Boyko
Format: Article
Language:Russian
Published: ABV-press 2022-11-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/632
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850024639796871168
author A. V. Pivnik
Y. G. Parhomenko
Y. A. Krivolapov
O. A. Tishkevich
V. G. Korovushkin
A. M. Kovrigina
M. B. Grusdev
L. D. Grinshpun
I. A. Berdisheva
N. V. Seregin
A. O. Tuaeva
E. B. Likunov
D. V. Boyko
author_facet A. V. Pivnik
Y. G. Parhomenko
Y. A. Krivolapov
O. A. Tishkevich
V. G. Korovushkin
A. M. Kovrigina
M. B. Grusdev
L. D. Grinshpun
I. A. Berdisheva
N. V. Seregin
A. O. Tuaeva
E. B. Likunov
D. V. Boyko
author_sort A. V. Pivnik
collection DOAJ
description We followed 66 lymphoma -AIDS patients (pts): aggressive lymphomas were diagnosed in 48 pts (male — 35, female — 13, median age 32.5±1.2) and Hodgkin's lymphoma was established in 18 pts (male — 14, female — 4, median age 34.1±2.3). Median duration time from HIV exposure to the onset of lymphomas was 5 years (2—16 years). A part of pts was receiving HAART. 85 % of pts were drug users and association with HCV was shown in 60 % of them, with HCV and HBV- in 25 %. Sexual transmission was mentioned in 15 % of pts. «Immune status»: CD4 counts were from 50 to 500 (median 225) cells in mcL. Viral load was from 400 to 75000 (median 38000) copies in mcL. Histological diagnosis: diffuse large cell lymphomas — 60%, Burkitt lymphoma — 16%, follicular lymphoma — 12%, MALT-lymphomas-6%, T- cell lymphoma — 4%, primary CNS lymphoma — 2%. CHOP and CHOP-like courses had received 26 pts. Results: 3-year overall survival — 52%, 3-year disease free survival — 32%. Block therapy A-B-C of BFM — NHL— 90 and LB-M-04 with and without Mabthera had received 12 pts. Results: 3-year overall survival — 48%, 3-year disease free survival — 38%. After treatment CD4 count was 60 — 700 (median 316) cells in mcL, viral load 400 to 25000 (median 3000) copies in mcL. 75% of Hodgkin's lymphoma patients had III—IV stages of disease. Initial immune status: CD4 counts from 50 to 730 (median 363) cells in mcL, viral load — from 14000 to 150 000 (median 100 000) copies in mcL. Histological variants: mixed cellularity — 14 pts, lymphoid depletion — 3 pts, nodular sclerosis — 1 pt. Chemotherapy had received 11 pts: ABVD with or without radiotherapy — 8 pts, BEACOPP-escalated with or without radiotherapy — 3 pts. Complete 3-year remissions were achieved in 2 pts. Other pts are on therapy. After treatment CD4 counts were 184 — 900 (median 400) cells in mcL, viral load — 435000 (median 100 000) copies in mcL. Modern treatment approaches in lymphoma -AIDS pts can lead to complete remission, as well as in general non-HIV positive population.
format Article
id doaj-art-e7356726dc7d4534a45aef59608aa874
institution DOAJ
issn 1818-8346
2413-4023
language Russian
publishDate 2022-11-01
publisher ABV-press
record_format Article
series Онкогематология
spelling doaj-art-e7356726dc7d4534a45aef59608aa8742025-08-20T03:01:03ZrusABV-pressОнкогематология1818-83462413-40232022-11-0103273710.17650/1818-8346-2007-0-3-27-37510Somatic problems of HIV-Medicine: AIDS-related lymphomasA. V. Pivnik0Y. G. Parhomenko1Y. A. Krivolapov2O. A. Tishkevich3V. G. Korovushkin4A. M. Kovrigina5M. B. Grusdev6L. D. Grinshpun7I. A. Berdisheva8N. V. Seregin9A. O. Tuaeva10E. B. Likunov11D. V. Boyko12N.I. Pirogov's National Medico-Surgical Center, Clinic and Chair of hematologyInfectious City Hospital № 2Leningrad Regional Pathology BureauInfectious City Hospital № 2Infectious City Hospital № 2N.N. Blokhin's Cancer Research CenterInfectious City Hospital № 2Clinical City Hospital № 60Clinical City Hospital № 60Clinical City Hospital № 60Clinical City Hospital № 60Federal Research Center of pediatric hematology, oncology and immunologyMedical AcademyWe followed 66 lymphoma -AIDS patients (pts): aggressive lymphomas were diagnosed in 48 pts (male — 35, female — 13, median age 32.5±1.2) and Hodgkin's lymphoma was established in 18 pts (male — 14, female — 4, median age 34.1±2.3). Median duration time from HIV exposure to the onset of lymphomas was 5 years (2—16 years). A part of pts was receiving HAART. 85 % of pts were drug users and association with HCV was shown in 60 % of them, with HCV and HBV- in 25 %. Sexual transmission was mentioned in 15 % of pts. «Immune status»: CD4 counts were from 50 to 500 (median 225) cells in mcL. Viral load was from 400 to 75000 (median 38000) copies in mcL. Histological diagnosis: diffuse large cell lymphomas — 60%, Burkitt lymphoma — 16%, follicular lymphoma — 12%, MALT-lymphomas-6%, T- cell lymphoma — 4%, primary CNS lymphoma — 2%. CHOP and CHOP-like courses had received 26 pts. Results: 3-year overall survival — 52%, 3-year disease free survival — 32%. Block therapy A-B-C of BFM — NHL— 90 and LB-M-04 with and without Mabthera had received 12 pts. Results: 3-year overall survival — 48%, 3-year disease free survival — 38%. After treatment CD4 count was 60 — 700 (median 316) cells in mcL, viral load 400 to 25000 (median 3000) copies in mcL. 75% of Hodgkin's lymphoma patients had III—IV stages of disease. Initial immune status: CD4 counts from 50 to 730 (median 363) cells in mcL, viral load — from 14000 to 150 000 (median 100 000) copies in mcL. Histological variants: mixed cellularity — 14 pts, lymphoid depletion — 3 pts, nodular sclerosis — 1 pt. Chemotherapy had received 11 pts: ABVD with or without radiotherapy — 8 pts, BEACOPP-escalated with or without radiotherapy — 3 pts. Complete 3-year remissions were achieved in 2 pts. Other pts are on therapy. After treatment CD4 counts were 184 — 900 (median 400) cells in mcL, viral load — 435000 (median 100 000) copies in mcL. Modern treatment approaches in lymphoma -AIDS pts can lead to complete remission, as well as in general non-HIV positive population.https://oncohematology.abvpress.ru/ongm/article/view/632aids-lymphomas in russiadiagnosis and treatment
spellingShingle A. V. Pivnik
Y. G. Parhomenko
Y. A. Krivolapov
O. A. Tishkevich
V. G. Korovushkin
A. M. Kovrigina
M. B. Grusdev
L. D. Grinshpun
I. A. Berdisheva
N. V. Seregin
A. O. Tuaeva
E. B. Likunov
D. V. Boyko
Somatic problems of HIV-Medicine: AIDS-related lymphomas
Онкогематология
aids-lymphomas in russia
diagnosis and treatment
title Somatic problems of HIV-Medicine: AIDS-related lymphomas
title_full Somatic problems of HIV-Medicine: AIDS-related lymphomas
title_fullStr Somatic problems of HIV-Medicine: AIDS-related lymphomas
title_full_unstemmed Somatic problems of HIV-Medicine: AIDS-related lymphomas
title_short Somatic problems of HIV-Medicine: AIDS-related lymphomas
title_sort somatic problems of hiv medicine aids related lymphomas
topic aids-lymphomas in russia
diagnosis and treatment
url https://oncohematology.abvpress.ru/ongm/article/view/632
work_keys_str_mv AT avpivnik somaticproblemsofhivmedicineaidsrelatedlymphomas
AT ygparhomenko somaticproblemsofhivmedicineaidsrelatedlymphomas
AT yakrivolapov somaticproblemsofhivmedicineaidsrelatedlymphomas
AT oatishkevich somaticproblemsofhivmedicineaidsrelatedlymphomas
AT vgkorovushkin somaticproblemsofhivmedicineaidsrelatedlymphomas
AT amkovrigina somaticproblemsofhivmedicineaidsrelatedlymphomas
AT mbgrusdev somaticproblemsofhivmedicineaidsrelatedlymphomas
AT ldgrinshpun somaticproblemsofhivmedicineaidsrelatedlymphomas
AT iaberdisheva somaticproblemsofhivmedicineaidsrelatedlymphomas
AT nvseregin somaticproblemsofhivmedicineaidsrelatedlymphomas
AT aotuaeva somaticproblemsofhivmedicineaidsrelatedlymphomas
AT eblikunov somaticproblemsofhivmedicineaidsrelatedlymphomas
AT dvboyko somaticproblemsofhivmedicineaidsrelatedlymphomas